Hispolon promotes MDM2 downregulation through chaperone-mediated autophagy

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Murine double minute (MDM2) amplification and overexpression are implicated in human cancers.
• While some chemotherapeutics target MDM2 via proteasomal degradation, alternative pathways may exist.
• Chaperone-mediated autophagy (CMA) is a lysosomal pathway for selective protein degradation involving Hsc70 and LAMP2A.

Purpose of the Study:

• To investigate the mechanism by which hispolon downregulates MDM2 expression.
• To determine if MDM2 degradation occurs through the proteasome or CMA pathway.
• To elucidate the role of Hsc70 and LAMP2A in hispolon-induced MDM2 downregulation.

Main Methods:

• Utilized proteasome inhibitor MG132 and lysosomal inhibitors (NH(4)Cl, siRNA targeting LAMP2A).
• Assessed MDM2 levels and protein interactions using immunoprecipitation and Western blotting.
• Investigated Hsc70-MDM2 interaction using SMP14 antibody and Hsc70 knockdown.
• Examined the effect of Hsp90 inhibitor geldanamycin (GA) on hispolon-induced effects.

Main Results:

• Hispolon-induced MDM2 downregulation was not affected by MG132 but was partially attenuated by lysosomal inhibition and LAMP2A knockdown.
• Hsc70 knockdown increased MDM2 immunoprecipitation by SMP14 antibody, suggesting Hsc70 interaction.
• Hispolon increased the association of Hsp70, Hsc70, Hsp90, and LAMP2A with MDM2.
• Geldanamycin and Hsc70 siRNA inhibited hispolon-induced MDM2 downregulation.

Conclusions:

• Hispolon downregulates MDM2 expression through the chaperone-mediated autophagy (CMA) lysosomal degradation pathway.
• This represents the first evidence of hispolon utilizing CMA for MDM2 downregulation.
• The findings highlight a novel therapeutic strategy targeting MDM2 in cancer via CMA modulation.